2026
article
OpenAlex
Lisa Laun, Alexander Leunig, Felix Zhang, Sezer Akgöl et autres
Platelets are essential to prevent blood loss and to orchestrate inflammation. Thrombotic complications of vascular disease and hyperresponsive platelets are associated with adverse outcomes, yet physiological mechanisms counteracting systemic platelet activation are poorly defined. In mice, we found that the spleen filters …
de, us, gb, fr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Siyu Sun, Rainer Kaiser, Johan W.M. Heemskerk, Leo Nicolai
Procoagulant platelets are characterized by sustained high cytosolic Ca2+, surface exposure of phosphatidylserine (PS) and P-selectin, and a balloon-shaped morphological transformation. These features strongly facilitate the generation of coagulation factor Xa and thrombin on the platelet membrane. Here, we provide a referenced …
nl, de
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Gemma Llovera, Steffanie Heindl, Dániel Péter Varga, Nikolett Lénárt et autres
Our research presents a new animal model of transient ischemic attack (TIA) that mimics brief episodes without cell loss, but results in neuronal and behavioral deficits. We identified excessive microglial reactivity, driven by acute ATP release, as a key factor in post-TIA …
de, hu, se
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Raphael Escaig, Lennart Kreutz, Rainer Kaiser, Leo Nicolai
A State of the Art lecture titled "Platelet effector functions in inflammation" was presented at the International Society on Thrombosis and Haemostasis congress in 2025. It is increasingly recognized that platelets are critical orchestrators of innate and adaptive immune responses. In this …
de
(code pays fourni par la source)
2026
review
OpenAlex
Rainer Kaiser, Leo Nicolai
de
(code pays fourni par la source)
2026
article
OpenAlex
Leo Nicolai
de
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Rainer Kaiser, Afra Anjum, Leo Nicolai
ABSTRACT: Platelets in peripheral blood critically drive clot formation in health and disease. Previously considered to uniformly respond to vascular injury and inflammatory cues, recent studies have highlighted that circulating platelets exhibit marked heterogeneity, with distinct populations contributing differentially to hemostasis, thrombosis, …
de
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Kilian Kirmes, Jiaying Han, Melissa Klug, Conor J. Bloxham et autres
BACKGROUND AND AIMS: Reticulated platelets (RPs), hyperreactive and RNA-rich, are associated with increased risk of cardiovascular events and suboptimal response to antiplatelet therapy in coronary artery disease (CAD). However, the underlying mechanisms remain poorly defined. This study aimed to characterize the molecular …
de, us, it
(code pays fourni par la source)
2025
article
OpenAlex
Yacine Boulaftali, Steffen Maßberg, Leo Nicolai
PURPOSE OF REVIEW: In this review, we aim to highlight recent insights into the mechanisms through which platelets contribute to vascular inflammation. We will discuss how platelets interact with other cellular players in the vascular milieu, their role in shaping inflammatory responses, …
fr, de
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Kami Pekayvaz, Badr Kilani, Markus Joppich, Luke Eivers et autres
phenotype. This immunothrombolytic axis results in thrombus resolution. Together, with this immune landscape of thrombosis, we provide a valuable resource and introduce the concept of "immunothrombolysis" with broad mechanistic and translational implications at the crossroad of inflammation and thrombosis.
de
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Max Esefeld, Stefan Handtke, Rainer Kaiser, Leo Nicolai et autres
ABSTRACT: Thrombosis and thrombocytopenia syndromes (TTS) describe immune-mediated thrombotic adverse reactions after vaccination against COVID-19. Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a well-known subentity of TTS, caused by adenovirus vector-based vaccines. VITT is mediated by anti-platelet factor 4 (PF4) immunoglobulin G (IgG) …
de, at, se
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Adrian Gottschlich, Ruth Grünmeier, Gordon Victor Hoffmann, Sayantan Nandi et autres
ABSTRACT: The success of targeted therapies for hematological malignancies has heralded their potential as both salvage treatment and early treatment lines, reducing the need for high-dose, intensive, and often toxic chemotherapeutic regimens. For young patients with classic Hodgkin lymphoma (cHL), immunotherapies provide …
de, no, nl, fr
(code pays fourni par la source)